Page last updated: 2024-09-03

esonarimod and Sensitivity and Specificity

esonarimod has been researched along with Sensitivity and Specificity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higaki, M; Inoue, T; Yamashita, M	1

Other Studies

1 other study(ies) available for esonarimod and Sensitivity and Specificity

Article	Year
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis. Rheumatology international, 2001, Volume: 20, Issue:4 Topics: Aged; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Base Sequence; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Electrophoresis; Female; Humans; Interleukin-1; Male; Middle Aged; Molecular Sequence Data; Phenylpropionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Synovial Membrane	2001

Article

Year

The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis.

Rheumatology international, 2001, Volume: 20, Issue:4

Topics: Aged; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Base Sequence; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Electrophoresis; Female; Humans; Interleukin-1; Male; Middle Aged; Molecular Sequence Data; Phenylpropionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Synovial Membrane

2001